HuGE Literature Finder
Records
1
-
30
| Clinical Outcomes after Percutaneous Coronary Intervention Over Time on the Basis of CYP2C19 Polymorphisms. Journal of cardiovascular pharmacology 2021 Oct . Zhang Yang, Zhao Xiliang, Ye Yicong, Li Quan, Zeng Yo |
| Bedside testing of CYP2C19 vs. conventional clopidogrel treatment to guide antiplatelet therapy in ST-segment elevation myocardial infarction patients. International journal of cardiology 2021 Sep . Al-Rubaish Abdullah M, Al-Muhanna Fahad A, Alshehri Abdullah M, Al-Mansori Mohammed A, Alali Rudaynah A, Khalil Rania M, Al-Faraidy Khalid A, Cyrus Cyril, Sulieman Mohammed M, Vatte Chittibabu, Loza Bao-Li, Claassens Daniel M F, Asselbergs Folkert W, Al-Ali Amein |
| Effects of Aging on Clinical Outcomes in Patients Receiving Genotype-Guided P2Y12 Inhibitor Selection after Percutaneous Coronary Intervention. Pharmacotherapy 2021 Jul . Wood Brian, Lee Craig R, Mulrenin Ian R, Gower Megan N, Rossi Joseph S, Weck Karen E, Stouffer George |
| Effect of CYP2C19 Genotype on Ischemic Outcomes During Oral P2Y Inhibitor Therapy: A Meta-Analysis. JACC. Cardiovascular interventions 2021 Apr 14 (7): 739-750. Pereira Naveen L, Rihal Charanjit, Lennon Ryan, Marcus Gil, Shrivastava Sanskriti, Bell Malcolm R, So Derek, Geller Nancy, Goodman Shaun G, Hasan Ahmed, Lerman Amir, Rosenberg Yves, Bailey Kent, Murad M Hassan, Farkouh Michael |
| Association between CYP2C19 polymorphisms and clinical outcomes in patients undergoing stent procedure for cerebral artery stenosis. Scientific reports 2021 Mar 11 (1): 5974. Li Yan-Jiao, Chen Xuan, Tao Li-Na, Hu Xin-Yuan, Wang Xin-Lu, Song Yan-Qi |
| Impact of genetic variants on clinical outcome after percutaneous coronary intervention in elderly patients. Aging 2021 Mar 13 (5): 6506-6524. Cha Jung-Joon, Park Jae Hyoung, Joo Hyung Joon, Hong Soon Jun, Ahn Tae Hoon, Kim Byeong-Keuk, Shin WonYong, Ahn Sung Gyun, Yoon JungHan, Kim Yong Hoon, Cho Yun-Hyeong, Kang Woong Chol, Kim Weon, Lim Young-Hyo, Gwon Hyeon Cheol, Choi Woong Gil, Lim Do-S |
| Effects of individualized antiplatelet therapy, based on CYP2C19 genotyping, on platelet function in patients underwent percutaneous coronary intervention. Perfusion 2020 Dec 267659120978584. Zhang Min, Wang Jiangrong, Zhang Yong, Zhang Pei, Chao Yangyang, Gao Mei, Hou Yinglo |
| Association of FMO3 rs1736557 polymorphism with clopidogrel response in Chinese patients with coronary artery disease. European journal of clinical pharmacology 2020 Oct . Zhu Kong-Xiang, Song Pei-Yuan, He-Li , Li Mu-Peng, Du Yin-Xiao, Ma Qi-Lin, Peng Li-Ming, Chen Xiao-Pi |
| Contribution of exome sequencing to the identification of genes involved in the response to clopidogrel in cardiovascular patients. Journal of thrombosis and haemostasis : JTH 2020 Feb . Fontana Pierre, Ibberson Mark, Stevenson Brian, Wigger Leonore, Daali Youssef, Niknejad Anne, Mach François, Docquier Mylène, Xenarios Ioannis, Cuisset Thomas, Alessi Marie-Christine, Reny Jean-L |
| Effect of Genotype-Guided Oral P2Y12 Inhibitor Selection vs Conventional Clopidogrel Therapy on Ischemic Outcomes After Percutaneous Coronary Intervention: The TAILOR-PCI Randomized Clinical Trial. JAMA 2020 08 324 (8): 761-771. Pereira Naveen L, Farkouh Michael E, So Derek, Lennon Ryan, Geller Nancy, Mathew Verghese, Bell Malcolm, Bae Jang-Ho, Jeong Myung Ho, Chavez Ivan, Gordon Paul, Abbott J Dawn, Cagin Charles, Baudhuin Linnea, Fu Yi-Ping, Goodman Shaun G, Hasan Ahmed, Iturriaga Erin, Lerman Amir, Sidhu Mandeep, Tanguay Jean-Francois, Wang Liewei, Weinshilboum Richard, Welsh Robert, Rosenberg Yves, Bailey Kent, Rihal Charanj |
| CYP2C19 genotype and adverse cardiovascular outcomes after stent implantation in clopidogrel-treated Asian populations: A systematic review and meta-analysis. Platelets 2019 30 (2): 229-240. Xi Ziwei, Fang Fang, Wang Jiayang, AlHelal Jumana, Zhou Yujie, Liu W |
| CRISPLD1 rs12115090 polymorphisms alters antiplatelet potency of clopidogrel in coronary artery disease patients in Chinese Han. Gene 2018 Aug . Wang Jie-Ya, Zhang Yan-Jiao, Li He, Hu Xiao-Lei, Li Mu-Peng, Song Pei-Yuan, Ma Qi-Lin, Peng Li-Ming, Chen Xiao-Pi |
| Clopidogrel Pharmacogenetics in Iranian Patients Undergoing Percutaneous Coronary Intervention. Cardiovascular toxicology 2018 May . Mahdieh Nejat, Rabbani Ahmad, Firouzi Ata, Zahedmehr Ali, Hoseinimoghaddam Maryam, Saeidi Sedigheh, Sanati Hamidreza, Basiri Hosseinali, Noohi Feridoun, Rabbani Bahareh, Maleki Maj |
| Gene polymorphisms in dual antiplatelet therapy and the presence of hypo-attenuated leaflet thickening after transcatheter aortic valve replacement. Journal of thrombosis and thrombolysis 2018 Feb . Xiong Tian-Yuan, Liao Yan-Biao, Feng Yuan, Zhao Ming-Yue, Zhao Zhen-Gang, Li Yi-Jian, Liu Xiao-Jing, Chen M |
| Integrative Medicine on Optimizing Clopidogrel and Aspirin Therapy. Chinese journal of integrative medicine 2018 Jan . Chen H |
| The CYP2C19*2 and CYP2C19*17 Polymorphisms play a Vital Role in Clopidogrel Responsiveness after Percutaneous Coronary Intervention: A Pharmacogenomics Study. Basic & clinical pharmacology & toxicology 2017 Jan . Saydam Faruk, De?irmenci ?rfan, Birdane Alparslan, Özdemir Mahmut, Ulus Taner, Özbayer Cansu, Çolak Ertu?rul, Ata Necmi, Güne? Hasan Vey |
| Effect of cytochrome P450 2C19*17 allelic variant on cardiovascular and cerebrovascular outcomes in clopidogrel-treated patients: A systematic review and meta-analysis. Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences 2017 22 109. Huang Bo, Cui De-Jun, Ren Ying, Han Bin, Yang Da-Ping, Zhao X |
| CYP2C19 genotyping combined with on-clopidogrel platelet reactivity in predicting major adverse cardiovascular events in Chinese patients with percutaneous coronary intervention. Thrombosis research 2016 Oct 147 108-114. Tang Xiao-Fang, Han Ya-Ling, Zhang Jia-Hui, Wang Jing, Yao Yi, He Chen, Xu Bo, Gao Zhan, Qiao Shu-Bin, Chen Jue, Wu Yuan, Chen Ji-Lin, Gao Run-Lin, Yang Yue-Jin, Yuan Jin-Qi |
| Gene polymorphism of CYP2C19*2, *3 and CYP3A4*1B and early stent thrombosis: case reports and literature review. Personalized medicine 2016 Sep 13 (5): 423-428. Kulmyrzaeva Nazgul, Tatarunas Vacis, Skipskis Vilius, Smagulova Gaziza, Seitmaganbetova Nazgul, Veikutiene Audrone, Lesauskaite Vai |
| CYP2C19 loss-of-function alleles are not associated with clinical outcome of clopidogrel therapy in patients treated with newer-generation drug-eluting stents. Medicine 2016 Jun 95 (26): e4049. Choi Ik Jun, Koh Yoon-Seok, Park Mahn-Won, Her Sung Ho, Choi Yun-Seok, Park Chul-Soo, Park Hun-Jun, Kim Pum-Joon, Chung Wook-Sung, Kim Ho-Sook, Shin Jae-Gook, Seung Ki-Bae, Chang Kiy |
| Simultaneous subacute coronary artery stent thrombosis in a carrier of two CYP2C19 loss-of function polymorphisms (*2/*3). International journal of cardiology 2016 Jun 212 148-50. Chikata Yuichi, Iwata Hiroshi, Osborn Eric A, Fukuda Kentaro, Okai Iwao, Shiozaki Masayuki, Kimura Yuki, Inoue Kenji, Fujiwara Yasumasa, Sumiyoshi Masata |
| Associations of CYP3A4, NR1I2, CYP2C19 and P2RY12 polymorphisms with clopidogrel resistance in Chinese patients with ischemic stroke. Acta pharmacologica Sinica 2016 May . Liu Rui, Zhou Zi-Yi, Chen Yi-Bei, Li Jia-Li, Yu Wei-Bang, Chen Xin-Meng, Zhao Min, Zhao Yuan-Qi, Cai Ye-Feng, Jin Jing, Huang M |
| Cytochrome allelic variants and clopidogrel metabolism in cardiovascular diseases therapy. Molecular biology reports 2016 Apr . Jarrar Mohammed, Behl Shalini, Manyam Ganiraju, Ganah Hany, Nazir Mohammed, Nasab Reem, Moustafa Khal |
| Evaluation of clopidogrel response variability and identification of the CYP2C19 polymorphism in Mexican patients. Archivos de cardiologia de Mexico 2016 Mar . Viveros Martha Eva, Areán Carlos, Gutiérrez Sergio, Vázquez Soledad, Cardiel Mario Humberto, Taboada Alejandra, Marín Gissela, Solorio Ruben, García Nall |
| Association between high on-treatment platelet reactivity and occurrence of cerebral ischemic events in patients undergoing percutaneous coronary intervention. Thrombosis research 2016 Feb 138 49-54. Komosa A, Siller-Matula J M, Lesiak M, Michalak M, Kowal J, M?czy?ski M, Siniawski A, Mularek-Kubzdela T, Wi?niewski S, Grajek |
| Effects of genetic factors to stent thrombosis due to clopidogrel resistance after coronary stent placement. Cellular and molecular biology (Noisy-le-Grand, France) 2016 62 (1): 51-5. Kirac D, Erdem A, Avcilar T, Yesilcimen K, Guney A I, Emre A, Yazici S, Terzi S, Kaspar E C, Cetin S E, Isbir |
| Correlates of pre-hospital morphine use in ST-elevation myocardial infarction patients and its association with in-hospital outcomes and long-term mortality: the FAST-MI (French Registry of Acute ST-elevation and non-ST-elevation Myocardial Infarction) programme. European heart journal 2015 Nov . Puymirat Etienne, Lamhaut Lionel, Bonnet Nicolas, Aissaoui Nadia, Henry Patrick, Cayla Guillaume, Cattan Simon, Steg Gabriel, Mock Laurent, Ducrocq Gregory, Goldstein Patrick, Schiele François, Bonnefoy-Cudraz Eric, Simon Tabassome, Danchin Nicol |
| Study design and rationale for Optimal aNtiplatelet pharmacotherapy guided by bedSIDE genetic or functional TESTing in elective percutaneous coronary intervention patients (ONSIDE TEST): a prospective, open-label, randomised parallel-group multicentre trial (NCT01930773). Kardiologia polska 2015 Sep . Ko?towski ?ukasz, Aradi Daniel, Huczek Zenon, Tomaniak Mariusz, Sibbing Dirk, Filipiak Krzysztof J, Kochman Janusz, Balsam Pawe?, Opolski Grzego |
| Cytochrome P450 CYP 2C19*2 Associated with Adverse 1-Year Cardiovascular Events in Patients with Acute Coronary Syndrome. PloS one 2015 10 (7): e0132561. Wei You-Quan, Wang Dian-Gang, Yang Hao, Cao He |
| Clopidogrel response variability: impact of genetic polymorphism and platelet biomarkers for predicting adverse outcomes poststenting. American journal of therapeutics 0 22 (3): 222-30. Golukhova Elena Z, Ryabinina Mariya N, Bulaeva Naida I, Grigorian Marina V, Kubova Maida Ch, Serebruany Victor |
- Page last reviewed:Oct 1, 2021
- Page last updated:May 26, 2022
- Content source: